The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
										The Bacampicillin Drug Master File in Japan (Bacampicillin JDMF) empowers Bacampicillin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
										PMDA reviews the Bacampicillin JDMF during the approval evaluation for pharmaceutical products. At the time of Bacampicillin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
										click here to find a list of Bacampicillin suppliers with JDMF on PharmaCompass.